Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Oligotrail LLC
Profile last edited on: 1/10/07      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1998
First Award
1998
Latest Award
2000
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2650 Ridge Avenue Suite 3212
Evanston, IL 60201
   (847) 570-2431
   N/A
   N/A
Location: Single
Congr. District: 09
County: Cook

Public Profile

Principal of the firm is a medical doctor on the staff of Evanston Hospital Department of Neurology - same address and phone number. He collaborated with Cobe Laboratories in developing an LDL-apheresis device which employed dextran-sulfate precipitation. Tested the safety and efficiency of the Cobe device in normal volunteers and FH patients. Employed the Cobe device and the Kaneka LA-40 columns (dextran-sulfate) in a randomized regression trial of CHD in non-FH patients. Participated in a multicenter safety and efficacy study of the Kaneka MA-02 LDL apheresis device which uses alternating LA-15 (dextran-sulfate) columns.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$99,516
Phase II Dollars
$749,614
Total Awarded
$849,130

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2000 2 NIH $849,130
Project Title: Locus Specific Bracketing Markers In Str Genotyping

Key People / Management

  Peter Dau

  Debang Liu

Company News

There are no news available.